| Primary |
| Hypertension |
25.8% |
| Cardiac Failure |
23.9% |
| Prophylaxis |
6.1% |
| Cardiac Failure Chronic |
5.6% |
| Acute Myocardial Infarction |
4.9% |
| Atrial Fibrillation |
3.8% |
| Cardiac Failure Congestive |
3.8% |
| Angina Pectoris |
3.1% |
| Diabetes Mellitus |
3.0% |
| Gastroenteritis |
3.0% |
| Thrombosis Prophylaxis |
2.5% |
| Hyperuricaemia |
2.2% |
| Constipation |
2.0% |
| Hypercholesterolaemia |
1.9% |
| Hyperlipidaemia |
1.8% |
| Insomnia |
1.7% |
| Pharyngitis |
1.4% |
| Cardiomyopathy Acute |
1.2% |
| Dyslipidaemia |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
|
| Renal Failure Acute |
14.4% |
| Bradycardia |
7.5% |
| Hyperkalaemia |
7.5% |
| Hyponatraemia |
7.5% |
| Renal Failure |
6.8% |
| Hepatic Function Abnormal |
6.2% |
| Toxic Nodular Goitre |
6.2% |
| Death |
5.5% |
| Pneumonia |
4.1% |
| Anaemia |
3.4% |
| Cerebral Infarction |
3.4% |
| Hypotension |
3.4% |
| Jaundice |
3.4% |
| Long Qt Syndrome |
3.4% |
| Renal Impairment |
3.4% |
| Acute Myeloid Leukaemia |
2.7% |
| Agranulocytosis |
2.7% |
| Blood Pressure Increased |
2.7% |
| Drug Ineffective |
2.7% |
| Oedema Peripheral |
2.7% |
|
| Secondary |
| Cardiac Failure |
21.6% |
| Hypertension |
16.0% |
| Product Used For Unknown Indication |
9.0% |
| Cardiac Failure Chronic |
7.9% |
| Gastroenteritis |
5.8% |
| Drug Use For Unknown Indication |
5.0% |
| Atrial Fibrillation |
4.7% |
| Rheumatoid Arthritis |
3.5% |
| Prophylaxis |
3.0% |
| Diabetes Mellitus |
2.9% |
| Thrombosis Prophylaxis |
2.7% |
| Hyperlipidaemia |
2.6% |
| Cardiac Failure Congestive |
2.3% |
| Insomnia |
2.3% |
| Myocardial Infarction |
2.2% |
| Constipation |
2.1% |
| Hyperuricaemia |
1.8% |
| Acute Myocardial Infarction |
1.7% |
| Gastritis Prophylaxis |
1.5% |
| Angina Pectoris |
1.4% |
|
| Renal Failure |
9.2% |
| Renal Failure Acute |
9.2% |
| Hyponatraemia |
7.6% |
| Hypotension |
7.6% |
| Hyperkalaemia |
6.7% |
| Malaise |
5.0% |
| Platelet Count Decreased |
5.0% |
| Pneumothorax |
5.0% |
| Vertigo |
5.0% |
| Angina Pectoris |
4.2% |
| Bradycardia |
4.2% |
| Ventricular Tachycardia |
4.2% |
| Anaemia |
3.4% |
| Cerebral Infarction |
3.4% |
| Death |
3.4% |
| Jaundice |
3.4% |
| Multi-organ Failure |
3.4% |
| Renal Failure Chronic |
3.4% |
| Syncope |
3.4% |
| Toxicity To Various Agents |
3.4% |
|
| Concomitant |
| Hypertension |
19.9% |
| Cardiac Failure |
16.7% |
| Product Used For Unknown Indication |
16.2% |
| Cardiac Failure Chronic |
6.6% |
| Prophylaxis |
4.7% |
| Atrial Fibrillation |
4.1% |
| Drug Use For Unknown Indication |
3.8% |
| Diabetes Mellitus |
3.3% |
| Glaucoma |
2.6% |
| Constipation |
2.5% |
| Hyperlipidaemia |
2.4% |
| Coronary Artery Disease |
2.1% |
| Myocardial Ischaemia |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Cardiac Failure Congestive |
2.0% |
| Cerebral Artery Embolism |
2.0% |
| Pain |
2.0% |
| Insomnia |
1.7% |
| Thrombosis Prophylaxis |
1.7% |
| Acute Coronary Syndrome |
1.6% |
|
| Renal Impairment |
10.3% |
| Cardiac Failure |
9.7% |
| Weight Increased |
7.2% |
| Urinary Tract Infection |
6.2% |
| Rhabdomyolysis |
5.6% |
| Ventricular Tachycardia |
5.6% |
| Vomiting |
5.6% |
| Progressive Multifocal Leukoencephalopathy |
5.1% |
| Renal Failure |
5.1% |
| Dyspnoea |
4.6% |
| Gastrointestinal Haemorrhage |
4.1% |
| Hyperuricaemia |
4.1% |
| Pneumonia |
4.1% |
| Dizziness |
3.6% |
| Fall |
3.6% |
| Anaemia |
3.1% |
| Cardiac Failure Acute |
3.1% |
| Myocardial Infarction |
3.1% |
| Sepsis |
3.1% |
| Urinary Retention |
3.1% |
|
| Interacting |
| Hypertension |
58.8% |
| Cardiac Failure |
20.0% |
| Pleural Effusion |
5.0% |
| Essential Hypertension |
3.8% |
| Atrial Fibrillation |
2.5% |
| Cardiomyopathy Acute |
2.5% |
| Oedema |
2.5% |
| Oedema Peripheral |
2.5% |
| Antifungal Prophylaxis |
1.3% |
| Diabetes Mellitus |
1.3% |
|
| Oedema Peripheral |
28.6% |
| Cardiac Failure |
14.3% |
| Drug Interaction |
14.3% |
| Renal Impairment |
14.3% |
| Hypotension |
7.1% |
| Renal Failure |
7.1% |
| Renal Failure Chronic |
7.1% |
| Rhabdomyolysis |
7.1% |
|
